Orna
Cambridge, US · Founded 2019 · 114 employees on LinkedIn · 3 known investors
Find your way into Orna
Sign up to see every warm intro you have to Orna
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Orna team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Orna Therapeutics develops RNA and lipid nanoparticle (LNP) based therapies for treating diseases including oncology and cell therapy applications. The company leverages proprietary drug development expertise in oRNA and LNP technology platforms.
Founders & leadership
Orna was founded in 2019 by Daniel Anderson and Thomas M. Barnes.






Investors · 3
How we know: Astellas Venture Management LLC's portfolio page · Not right? Tell us
How we know: MPM BioImpact's portfolio page · a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
Funding
SEC filings, press & company announcements$120.6M disclosed across 1 of 3 rounds · 2021–2022
- Undisclosed amountSeed RoundJun 2022Source ↗
▶$120.6MraisedAug 2022 · 17 investors · BiotechnologyRule 506(b)
- Brian GoodmanDirector
- Sakae AsanumaDirector
- Daniel AndersonDirector
- Robert MarbyExecutive Officer
- John McCabeExecutive Officer
- William ShenExecutive Officer
- Morana Jovan-EmbiricosDirector
- Nishla KeiserExecutive Officer
- Thomas EbelingDirector
- Francesco MarincolaDirector
- Ansbert GadickeDirector
- Thomas M. BarnesExecutive Officer, Director
- Offering amount
- $300M
- Amount sold
- $120.6M
- First sale
- Aug 2022
- Incorporated
- Limited Liability Company, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
Companies working in the same space as Orna.
In the news
Frequently asked questions
- What does Orna do?
- Orna Therapeutics develops RNA and lipid nanoparticle (LNP) based therapies for treating diseases including oncology and cell therapy applications. The company leverages proprietary drug development expertise in oRNA and LNP technology platforms.
- Who founded Orna?
- Orna was founded by Daniel Anderson, Thomas M. Barnes in 2019.
- Who are Orna's investors?
- Orna's investors include Astellas Venture Management LLC, MPM BioImpact, Taiho Ventures, LLC.
- How much funding has Orna raised?
- Orna has disclosed $120.6M raised across 1 of its 3 known rounds.
- Where is Orna headquartered?
- Orna is headquartered in Cambridge, US.








